North Carolina Physicians' Group Calls for Halt to Atrium COVID Vaccine Trial for Children
19 mai 2022 20h00 HE
|
NC Physicians For Freedom
WINSTON-SALEM, N.C., May 19, 2022 (GLOBE NEWSWIRE) -- The North Carolina Physicians for Freedom (NCPFF), a large network of physicians and other health care professionals, called for the cessation...
First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida
01 sept. 2020 09h00 HE
|
Headlands Research
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida,...
Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial
11 août 2020 09h00 HE
|
Headlands Research
SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine...
Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials
16 juil. 2020 13h28 HE
|
Headlands Research
SAN FRANCISCO, July 16, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials....
INC Research Bolsters Support for Vaccine Trials through Expanded Site and Patient Initiatives
06 avr. 2017 14h52 HE
|
INC Research, LLC
RALEIGH, N.C., April 06, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, will demonstrate its continued commitment...
INC Research Extends Catalyst Program with Launch of Vaccine Catalyst Site Network
27 juil. 2016 09h52 HE
|
INC Research, LLC
RALEIGH, N.C., July 27, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the launch of the...